Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24h in Healthy Japanese Subjects Makoto Araie, Baldo Scassellati Sforzolini, Jason Vittitow, Robert N. Weinreb

July 21, 2021

View Press Release Corporate presentation Contact us
Previous